EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer
The EMA's CHMP has recommended approval of a combination therapy of BMS's Opdivo...
AHA 2024: lerodalcibep provides promising results in op...
At AHA 2024, clinical trial results were presented from the ongoing open-label e...
AHA 2024: Plozasiran demonstrates promising Phase III r...
During AHA 2024, data were presented from the Phase III trial of plozasiran targ...